Abstract
Impairment of hearing is the most common sensory deficit in human populations. Most cases of human deafness are hereditary. Mutations in many different genes can affect the complex process of hearing. The mouse is an excellent model for studies of these hearing disorders because the anatomy, function, and hereditary abnormalities of the ear have been shown to be similar in both humans and mice. More than 100 spontaneous, chemically-induced, and genetically engineered mouse mutations have been discovered with hearing impairment many of these provide valuable models for both non-syndromic and syndromic forms of human deafness. So far, a total of 64 loci for human non-syndromic hearing impairment have been mapped, the genes responsible for 20 have been identified, and mouse models are available for 8 of these genes. More than 400 human syndromes have been described with associated hearing impairment, and about 80 genes have been identified. Mutations of homologous genes in the mouse have provided models for many of these syndromes. Studies of human hearing disorders and their mouse counterparts have contributed much to our understanding of the hearing process. For example, they have identified molecules (unconventional myosins, espins, and cadherins) that are important for the proper organization of hair cell stereocilia, ion transport and gap junction proteins that regulate endocochlear ion concentrations, and extracellular matrix proteins that compose acellular membranes important in auditory transduction. Genetically diverse inbred strains of mice provide models of age-related and noise-induced hearing loss and also provide a means to discover modifier genes by assessing mutant phenotypes on different strain backgrounds. With the new human and mouse genome initiatives now underway, the mouse will become an even more important animal model for hearing research.
Keywords: human hearing disorder, hereditary deafness, spontaneous mutation, genetically engineered, non syndromic, modifier genes
Current Genomics
Title: Mouse Models of Human Hearing Disorders
Volume: 2 Issue: 1
Author(s): Kenneth R. Johnson
Affiliation:
Keywords: human hearing disorder, hereditary deafness, spontaneous mutation, genetically engineered, non syndromic, modifier genes
Abstract: Impairment of hearing is the most common sensory deficit in human populations. Most cases of human deafness are hereditary. Mutations in many different genes can affect the complex process of hearing. The mouse is an excellent model for studies of these hearing disorders because the anatomy, function, and hereditary abnormalities of the ear have been shown to be similar in both humans and mice. More than 100 spontaneous, chemically-induced, and genetically engineered mouse mutations have been discovered with hearing impairment many of these provide valuable models for both non-syndromic and syndromic forms of human deafness. So far, a total of 64 loci for human non-syndromic hearing impairment have been mapped, the genes responsible for 20 have been identified, and mouse models are available for 8 of these genes. More than 400 human syndromes have been described with associated hearing impairment, and about 80 genes have been identified. Mutations of homologous genes in the mouse have provided models for many of these syndromes. Studies of human hearing disorders and their mouse counterparts have contributed much to our understanding of the hearing process. For example, they have identified molecules (unconventional myosins, espins, and cadherins) that are important for the proper organization of hair cell stereocilia, ion transport and gap junction proteins that regulate endocochlear ion concentrations, and extracellular matrix proteins that compose acellular membranes important in auditory transduction. Genetically diverse inbred strains of mice provide models of age-related and noise-induced hearing loss and also provide a means to discover modifier genes by assessing mutant phenotypes on different strain backgrounds. With the new human and mouse genome initiatives now underway, the mouse will become an even more important animal model for hearing research.
Export Options
About this article
Cite this article as:
Johnson R. Kenneth, Mouse Models of Human Hearing Disorders, Current Genomics 2001; 2 (1) . https://dx.doi.org/10.2174/1389202013351156
DOI https://dx.doi.org/10.2174/1389202013351156 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advanced Echocardiographic Imaging of the Congenitally Malformed Heart
Current Cardiology Reviews Development of a Registry for Down Syndrome in the Gulf Area of the Middle East
Applied Clinical Research, Clinical Trials and Regulatory Affairs Pituitary Stem Cells Drop Their Mask
Current Stem Cell Research & Therapy Autologous Fat Transfer and Cell-Based Strategies for Soft Tissue Reconstruction
Current Tissue Engineering (Discontinued) Anti-CD20 in Targeting B Lymphocytes for the Treatment of Autoimmune Diseases: Clinical Benefits and Insights into the Role of B Lymphocytes in Pathophysiology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Spinal Muscular Atrophy: Molecular Mechanisms
Current Molecular Medicine Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) microRNA-133: Expression, Function and Therapeutic Potential in Muscle Diseases and Cancer
Current Drug Targets Tissue Factor and Atherothrombosis
Current Pharmaceutical Design Detection of Unilateral Hearing Loss by Stationary Wavelet Entropy
CNS & Neurological Disorders - Drug Targets 3D Printing in Modern Cardiology
Current Pharmaceutical Design DNA Methylation, An Epigenetic Mode of Gene Expression Regulation in Reproductive Science
Current Pharmaceutical Design Novel Antiviral Strategies to Combat Human Arenavirus Infections
Current Molecular Medicine Perinatal Management of Fetal Tumors
Current Pediatric Reviews Vasculogenic and Angiogenic Pathways in Moyamoya Disease
Current Medicinal Chemistry Voltage-Gated Sodium Channels: Mutations, Channelopathies and Targets
Current Medicinal Chemistry From the Oxygen to the Organ Protection: Erythropoietin as Protagonist in Internal Medicine
Cardiovascular & Hematological Agents in Medicinal Chemistry FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment
Current Medicinal Chemistry Targeting the Secretory Pathway for Anti-Inflammatory Drug Development
Current Topics in Medicinal Chemistry Coated with Nanomaterials Intraocular Lenses, Ophthalmic and Human Body Implantable Devices with High Catalytic Antioxidant Activities: A New Nanotechnology Strategy of Peroxidase Cellular Enzyme Mimics Increasing the Biocompatibility and Therapeutic Deployment of the Medical Prosthetic Device
Recent Patents on Drug Delivery & Formulation